The menin-KMT2A interaction promotes aberrant HOXA/MEIS1 expression across various recurrent AML genotypes and has emerged as a prominent molecular dependency that may be disrupted by a new class of selective molecules. This evidence concerns the gene MEIS1 and acute myeloid leukemia.